Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADVM | AZN | AMGN | GILD | BMY |
| Company | Adverum Biotechnologies Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 4.24 | 170.64 | 369.23 | 131.83 | 61.40 |
| High | 4.38 | 170.89 | 371.00 | 132.86 | 61.70 |
| Low | 4.23 | 168.46 | 364.86 | 130.23 | 60.56 |
| Latest | 4.36 | 169.73 | 366.05 | 130.34 | 60.76 |
| Change | +0.10 | +0.39 | -0.19 | +0.06 | -0.17 |
| % Change | +2.35% | +0.23% | -0.05% | +0.05% | -0.28% |
| Volume | 1,023,000 | 1,683,693 | 1,547,774 | 4,756,797 | 6,796,047 |
| 20-Day Average Volume | 498,235 | 2,741,255 | 2,253,044 | 7,533,615 | 11,759,603 |
| Previous Close | 4.26 | 169.34 | 366.24 | 130.28 | 60.93 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.22 | 179.17 | 362.93 | 130.54 | 58.22 |
| 20-Day Raw Stochastic | 95.22% | 17.53% | 61.62% | 39.37% | 79.64% |
| 20-Day Relative Strength | 55.48 | 42.72 | 56.60 | 49.60 | 57.80 |
| Weighted Alpha | -8.15 | +6.06 | +20.30 | +8.96 | +26.78 |
| Today's Opinion | 64% Buy | 88% Sell | 72% Buy | 40% Sell | 72% Buy |
| Previous Opinion | 56% Buy | 88% Sell | 72% Buy | 32% Sell | 56% Buy |
| Last Month's Opinion | 72% Buy | 72% Sell | 24% Buy | 72% Sell | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.81% since 12/01/25 | +0.81% since 07/15/26 | +2.16% since 07/15/26 | -1.03% since 07/15/26 | +3.47% since 07/15/26 |
| Low | 4.15 on 12/05/25 | 164.06 on 07/20/26 | 357.74 on 07/16/26 | 129.13 on 07/21/26 | 58.57 on 07/16/26 |
| High | 4.38 on 12/08/25 | 170.89 on 07/22/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 1-Month | |||||
| %Chg | +0.93% since 11/07/25 | -3.80% since 06/22/26 | +6.19% since 06/22/26 | +4.38% since 06/22/26 | +11.08% since 06/22/26 |
| Low | 3.99 on 11/25/25 | 164.06 on 07/20/26 | 345.49 on 06/23/26 | 123.67 on 06/25/26 | 54.78 on 06/24/26 |
| High | 4.38 on 12/08/25 | 196.41 on 07/02/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 3-Month | |||||
| %Chg | +23.16% since 09/08/25 | -12.87% since 04/22/26 | +5.82% since 04/22/26 | -1.93% since 04/22/26 | +3.33% since 04/22/26 |
| Low | 2.87 on 09/17/25 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 5.75 on 10/02/25 | 196.64 on 04/23/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 6-Month | |||||
| %Chg | +54.06% since 06/06/25 | -7.44% since 01/22/26 | +5.47% since 01/22/26 | -0.61% since 01/22/26 | +10.59% since 01/22/26 |
| Low | 2.11 on 07/01/25 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 5.75 on 10/02/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 96,256 | 262,630,736 | 197,662,656 | 161,751,728 | 124,423,392 |
| Shares Outstanding, K | 22,077 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 1,000,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -130,930,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -47,650,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 0.87 | 0.24 | 0.41 | 0.32 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.03 on 11/12/25 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 04/21/26 | 07/27/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 07/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 07/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.77 | 16.48 | 15.92 | 10.15 |